Company: MDCXW
Filing Date: 2025-11-19
Form Type: S-1
Source: 0001062993-25-016962
Chunk: 232

Company: Medicus Pharma Ltd.
Filing Date: 2025-11-19
Form: S-1
Chunk 232
---
 | $ | 359,011 |
| Accrued compensation and benefits |   |                 140,989 |     |   |  27,766 |
| Accrued other                     |   |                 126,830 |     |   |  18,040 |
|                                   | $ |                 762,835 |     | $ | 404,817 |

5. Leases

As of December 31, 2024, the Company had one operating lease for its corporate office that commenced in 2024, for which the Company recorded a right-of-use asset and lease liability as of the commencement date. The Company's lease does not contain a purchase option. Where the Company's lease contains an option to extend the lease term, the extended lease term is only included in the measurement of the lease when it is reasonably certain to remain in the lease beyond the non-cancellable term. The Company's lease also contains variable lease costs, which pertain to common area maintenance and other operating charges, that are expensed as incurred.

Balance sheet information related to the Company's lease is presented below:

|                                           |   |   Year Ended 
 December 31, 
         2024 |
|:------------------------------------------|:--|-------------:|
| Operating lease                           |   |              |
| Operating lease right-of-use assets       | $ |      268,571 |
| Operating lease liabilities - current     |   |      116,323 |
| Operating lease liabilities - non-current |   |      205,945 |

Other information related to leases is presented below:

|                                               |   |   Year Ended 
 December 31, 
         2024 |   |
|:----------------------------------------------|:--|-------------:|:--|
| Lease cost                                    |   |              |   |
| Operating lease cost                          | $ |      123,777 |   |
| Other information                             |   |              |   |
| Operating cash flows used in operating leases |   |      (70,080 | ) |
| Remaining lease term (in years)               |   |         2.42 |   |
| Discount rate                                 |   |          10% |   |

As of December 31, 2024, the annual future minimum lease payments of the Company's operating lease liabilities were as follows:

<div align='center'>F-16</div>

| Year ending December 31,                          
 2026                                              |   | 146,530 |   |
|: